LabCorp v. Metabolite, Inc., 548 U.S. 124 (2006), is the first case since Diamond v. Chakrabarty in which the U.S. Supreme Court indicated a renewed interest in examining the limits of patentable subject matter for advances in life sciences.
LabCorp v. Metabolite, Inc., 548 U.S. 124 (2006), represents the initial case following Diamond v. Chakrabarty where the Supreme Court demonstrated a renewed focus on determining the limits of patentable subject matter in life sciences.